Nobel winning mRNA tech publicly funded, not by pharma
The mRNA vaccine technology against Covid-19, which on Monday received the 2023 Nobel for Medicine was publicly funded and not by pharma giants, said the People's Vaccine Alliance.
The mRNA vaccine technology against Covid-19, which on Monday received the 2023 Nobel for Medicine was publicly funded and not by pharma giants, said the People's Vaccine Alliance.
![\](https://assets.thehansindia.com/h-upload/2025/04/10/500x300_1541135-supreme-court-of-india.webp "\")
